2023
Our Subsidiary, Marcan Pharmaceuticals Inc., acquired Mantra Pharma Inc.
Our Subsidiary, Marcan Pharmaceuticals Inc., acquired Mantra Pharma Inc.
Zuventus, established a manufacturing facility at Bengaluru, Karnataka.
Our Subsidiary, Emcure UK acquired Bhardwaj Pharma GmbH (now known as Tillomed Pharma GmbH)
Acquired Marcan Pharmaceuticals Inc., Canada
Our Subsidiary, Emcure UK acquired Tillomed Laboratories Limited. BC Investments IV Limited acquired Blackstone's stake in Emcure.
Worldwide rights of BICNU acquired.
Commenced EU operations with formation of Emcure UK
Commenced production of tablets and capsules at our facility at Jammu.
Facility established by Gennova at Hinjawadi, Pune, became operational. Gennova received an approval from the Central Drugs Standard Control Organisation to start manufacturing “Recombinant Tissue Plasminogen Activator ((TNK-t-PA).
Blackstone GPV Capital Partners Mauritius V-C Ltd. made a total investment of ₹2,250 million in the Company.
Established a facility at Kurkumbh, Pune.
Injectable & Emcure Biotech Ltd. (now Gennova biopharmaceuticals limited) facility operational
Zuventus Healthcare Limited incorporated
Gennova Biopharmaceuticals Limited incorporated
Emcure Pharmaceuticals Private Limited incorporated
